InvestorsHub Logo
Followers 1
Posts 44
Boards Moderated 0
Alias Born 03/30/2021

Re: Fiberman post# 47073

Thursday, 04/08/2021 12:30:59 PM

Thursday, April 08, 2021 12:30:59 PM

Post# of 50668
I agree there may definitely be confirmation-bias, myself included, along with those who are simply trying to pump it up. The fact that a minimum investment could potential mean huge returns is very appealing and exciting. I am still researching this almost daily.

There are three facts that I have been able to verify that I am currently cling too however:

1. The Fa2N-4 patent has been renewed by a company called MCET. Whether or not the company is active, real or not, the patent has been renewed.

2. Xenotech is still selling Fa2N-4. I've attached below where you could buy it yourself if you like.

https://www.xenotech.com/in-vitro-test-systems/cell-products/primary-human-hepatocytes/plateable/immortalized/

3. LA JOLLA COVE INVESTORS, INC. has maintained 9.99% ownership of the company, last filing 2019.

https://www.xenotech.com/in-vitro-test-systems/cell-products/primary-human-hepatocytes/plateable/immortalized/

Again, totally agree that pumpers exists and many like myself are clinging to other 'confirmational biased' articles, statements, etc. I am also very interested in knowing more about the research company that keeps publishing their research on different websites for sale. Again, it makes it exciting that Johnson and Johnson is listed next to it but don't know the validity of the company or research. I won't be buying it. See below for the most recent one:

https://bisouv.com/uncategorized/4053332/toll-like-receptor-3-market-2021-is-rapidly-increasing-worldwide-in-near-future-top-companies-analysis-biomics-biotechnologies-co-ltd-hemispherx-biopharma-inc-idera-pharmaceuticals-inc-innat/